In the BioHarmony Drug Report Database
Polyethylene glycol
Miralax, Mircera (polyethylene glycol) is a small molecule pharmaceutical. Polyethylene glycol was first approved as Miralax on 2006-10-06. It has been approved in Europe to treat anemia and chronic kidney failure.
Trade Name
|
Mircera |
|---|---|
Common Name
|
polyethylene glycol |
ChEMBL ID
|
CHEMBL1201478 |
Indication
|
anemia, chronic kidney failure |
Drug Class
|
Image (chem structure or protein)
